My title



“Extended use of dabigatran, warfarin or placebo in VTE”;”Apixaban for extended treatment of VTE” and editorial “Extended treatment of VTE”

by jmiller on February 26, 2013

Three studies reported in two articles (NEJM, Feb 21) examine the efficacy and safety of two new oral anticoagulants for extended treatment of unprovoked vte after initial anticoagulation therapy.  The editorail concludes “Dabigatran was effective in the extended treatment of vte and carried a lower risk of major or clinically relevant bleeding than warfarin but a higher risk than placebo.  Click here to read all three.